| Defining the carrier proteome limit for single-cell proteomics TK Cheung, CY Lee, FP Bayer, A McCoy, B Kuster, CM Rose Nature Methods 18 (1), 76-83, 2021 | 167 | 2021 |
| Mining the human tissue proteome for protein citrullination CY Lee, D Wang, M Wilhelm, DP Zolg, T Schmidt, K Schnatbaum, ... Molecular & Cellular Proteomics 17 (7), 1378-1391, 2018 | 110 | 2018 |
| Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing J Zecha, CY Lee, FP Bayer, C Meng, V Grass, J Zerweck, K Schnatbaum, ... Molecular & Cellular Proteomics 19 (9), 1503-1522, 2020 | 92 | 2020 |
| Mass spectrometry-based draft of the mouse proteome P Giansanti, P Samaras, Y Bian, C Meng, A Coluccio, M Frejno, ... Nature methods 19 (7), 803-811, 2022 | 32 | 2022 |
| Probing the roles of calcium-binding sites during the folding of human peptidylarginine deiminase 4 YL Liu, CY Lee, YN Huang, HY Chen, GY Liu, HC Hung Scientific reports 7 (1), 2429, 2017 | 24 | 2017 |
| Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor YC Liu, CY Lee, CL Lin, HY Chen, GY Liu, HC Hung Oncotarget 6 (27), 23917, 2015 | 15 | 2015 |
| Molecular interplay between the dimer interface and the substrate-binding site of human peptidylarginine deiminase 4 CY Lee, CC Lin, YL Liu, GY Liu, JH Liu, HC Hung Scientific Reports 7 (1), 42662, 2017 | 13 | 2017 |
| Functional roles of the dimer-interface residues in human ornithine decarboxylase CY Lee, YL Liu, CL Lin, GY Liu, HC Hung PLoS One 9 (8), e104865, 2014 | 12 | 2014 |
| Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics CY Lee, M The, C Meng, FP Bayer, K Putzker, J Müller, J Streubel, ... Molecular Systems Biology 20 (1), 28-55, 2024 | 3 | 2024 |
| Regulation of polyamine homeostasis through an antizyme citrullination pathway YF Yang, CY Lee, JY Hsieh, YL Liu, CL Lin, GY Liu, HC Hung Journal of Cellular Physiology 236 (8), 5646-5663, 2021 | 2 | 2021 |
| Therapeutic implications of phosphoproteomics in molecular cancer diagnostics. A Schneider, J Woortman, CB Jensen, A Sakhteman, MV Teleanu, ... Journal of Clinical Oncology 42 (16_suppl), 3068-3068, 2024 | | 2024 |
| Enhancing treatment recommendations in precision oncology with proteomics and phosphoproteomics data CR Jensen, A Schneider, A Sakhteman, J Woortman, C Göbel, F Hamood, ... Genetoberfest 2023, 2023 | | 2023 |
Bernhard KusterProfessor for Proteomics and Bioanalytics在 tum.de 的电子邮件经过验证
